JavaScript is disabled. Please enable to continue!

Mobile search icon
Food Testing >> Resources >> Vitafoods Europe 2026 Trends: Innovation Is Moving Fast. Commercial Reality Is Catching Up

Vitafoods Europe 2026 Trends: Innovation Is Moving Fast. Commercial Reality Is Catching Up

Sidebar Image

After a few days at Vitafoods Europe 2026, one thing became clear: innovation in the nutraceutical and functional food space is accelerating, but commercialization is struggling to keep pace.

There was no shortage of new concepts. From high-protein RTDs to next-generation delivery formats and microbiome-targeted ingredients, the industry continues to push forward aggressively.

But the most important takeaway wasn’t what’s new.
It was where things are breaking.

The conversation is shifting from “What can we formulate?” to a much harder question:
“What will actually work in a factory, at scale, for 12+ months?”

High Performance Is No Longer Differentiation. It’s Expected.

Across the show floor, several macro trends dominated:

  • High-protein beverages and RTDs, with 20–30g now a baseline expectation
  • GLP-1 aligned products focused on satiety, portion control, and metabolic health
  • Microbiome and women’s health-focused ingredients, including more targeted positioning around hormonal health and gut health
  • Longevity-focused ingredients tied to cellular health, cognition, and metabolic function
  • Clean label formulations that still aim to deliver full functionality

Individually, none of these are new. What’s changed is that brands are now expected to deliver all of them simultaneously.

Consumers are no longer choosing between functionality, taste, convenience, or ingredient transparency. They expect all four.

That combination creates a level of technical tension that many teams are still underestimating.

Longevity Is Moving from Narrative to Formulation Challenge

Longevity was a consistent theme across Vitafoods Europe 2026, but it’s evolving.

Rather than broad “healthy aging” messaging, there’s a shift toward more specific, biologically grounded applications. Ingredients tied to cellular health, metabolic function, cognitive support, and inflammation pathways are positioned with greater precision.

What’s changing is that longevity is starting to influence real product decisions:

  • Ingredient selection
  • Dose targets
  • Format choices
  • Daily use positioning

At the same time, it introduces complexity.

Many of these ingredients come with challenges around stability, bioavailability, taste, and effective dosing. Translating them into formats that consumers will use consistently, and that can scale, is not straightforward.

There is also growing overlap between longevity and women’s health, particularly around hormonal and metabolic health. As these categories converge, formulation and delivery become even more nuanced.

Delivery Formats Are Shifting Toward Lower Friction, Higher Impact

One of the most meaningful shifts wasn’t just ingredients — it was how they’re being delivered.

RTDs, gummies, and stick packs are still dominant. But innovation is clearly moving toward smaller, more concentrated, and more convenient formats.

I kept seeing the same pattern:

  • Less volume
  • Less prep
  • Faster consumption

This showed up in different ways:

  • Concentrated liquid shot formats
  • Reworked effervescent systems that feel more like beverages
  • Hybrid formats that blur the line between solid and liquid
  • More advanced stick pack systems

And increasingly, melt-in-mouth delivery systems.

Melt-in-Mouth Formats Highlight the Tradeoffs

Several companies were showcasing powder-based systems designed to dissolve directly on the tongue, no water required.

The appeal is obvious: instant, portable, frictionless.

But the tradeoffs are just as clear.

Without dilution, taste becomes much harder to manage. Bitter actives are fully exposed, and mouthfeel becomes critical. There are also inherent limitations on dose, making these formats better suited for targeted actives rather than macronutrients.

On the backend, moisture sensitivity, packaging, and manufacturing constraints add another layer of complexity.

Like many innovations at Vitafoods, these formats are compelling at a concept level. But making them work consistently at scale is a different challenge entirely.

Convenience Is Driving Innovation… and Increasing Risk

Across formats, a consistent theme emerges:

The simpler the product feels to the consumer, the more complex it is to execute.

Convenience-driven design introduces real technical challenges:

  • Water activity and stability
  • Ingredient compatibility
  • Powder flow and dissolution
  • Shelf-life performance

Many of the concepts on display are strong ideas. But a significant number have not yet been validated under real manufacturing conditions.

That gap between prototype and production remains one of the biggest risks in the industry.

The Real Shift: Commercialization Risk Is Now Front and Center

What felt different this year was the tone of conversations.

More brands are asking:

  • Will this hold up under real processing conditions
  • Will it maintain texture and stability over time
  • Will a co-manufacturer actually run this

These are no longer secondary questions. They’re becoming central.

Innovation is no longer the bottleneck.
Execution is.

Conclusion: The Next Phase of Innovation Is Execution

Vitafoods Europe 2026 continues to be one of the best places to see where the industry is heading.

But the biggest takeaway from this year isn’t about trends.
It’s about viability.

The next wave of winners will be the companies that can consistently translate innovation into products that perform at scale, over time, and across manufacturing environments.

 

Meet the Author

Rachel Taylor | Director of Commercial Strategy, Eurofins Product Development & Innovation

Rachel Taylor is Director of Commercial Strategy at Eurofins Product Development & Innovation, where she leads commercial efforts across food, beverage, and nutrition innovation.

Her role focuses on connecting technical capabilities with real business needs, with an emphasis on how products move from concept into scalable, commercially viable solutions. She works closely with R&D teams, founders, and commercial stakeholders to translate complex challenges into clear, actionable pathways forward.

Rachel attended Vitafoods Europe 2026 to connect with industry leaders and gain firsthand perspective on the trends shaping the next generation of functional products.

 

Continuing the Conversation

If you’re developing a product that needs to balance high functionality, clean label expectations, and scalable delivery formats, you’re likely running into many of the challenges outlined here.

We are happy to connect and share perspective, especially around feasibility, scale-up, and how concepts translate beyond the bench.

Eurofins Product Development & Innovation partners with food, beverage, and nutrition brands to support product development from early feasibility through pilot and commercialization. The team focuses on reducing technical risk, validating formulations under real processing conditions, and helping ensure products perform consistently at scale

Connect with an expert.

https://www.eurofinsus.com/food-testing